Prime Medicine (PRME) Insider Trading & Ownership $4.67 +0.66 (+16.46%) Closing price 04:00 PM EasternExtended Trading$5.08 +0.41 (+8.67%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Prime Medicine (NYSE:PRME) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage22.74%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$10.11MNumber OfInsiders Selling(Last 12 Months)0 Get PRME Insider Trade Alerts Want to know when executives and insiders are buying or selling Prime Medicine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRME Insider Buying and Selling by Quarter Prime Medicine Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/1/2025Arch Venture Partners Xii, LlcMajor ShareholderBuy3,030,300$3.30$9,999,990.00 6/23/2025David R LiuMajor ShareholderBuy21,000$2.16$45,360.00 6/16/2025David R LiuMajor ShareholderBuy21,000$1.49$31,290.00 6/11/2025David R LiuMajor ShareholderBuy21,000$1.60$33,600.00 (Data available from 1/1/2013 forward) PRME Insider Trading Activity - Frequently Asked Questions Who is on Prime Medicine's Insider Roster? The list of insiders at Prime Medicine includes 2019 Gp L.L.C. Gv, Arch Venture Partners Xii, Llc, David R Liu, and Robert Nelsen. Learn more on insiders at PRME. What percentage of Prime Medicine stock is owned by insiders? 22.74% of Prime Medicine stock is owned by insiders. Learn more on PRME's insider holdings. Which Prime Medicine insiders have been buying company stock? The following insiders have purchased PRME shares in the last 24 months: Arch Venture Partners Xii, Llc ($9,999,990.00), David R Liu ($110,250.00), and Robert Nelsen ($20,000,000.00). How much insider buying is happening at Prime Medicine? Insiders have purchased a total of 6,293,300 PRME shares in the last 24 months for a total of $30,110,240.00 bought. Prime Medicine Key ExecutivesDr. Keith Michael Gottesdiener M.D. (Age 70)Ph.D., President, CEO, Secretary & Director Compensation: $1.06MDr. Ann L. Lee Ph.D. (Age 62)Chief Technical Officer Compensation: $684.78kDr. Jeremy S. Duffield M.D. (Age 56)Ph.D., Chief Scientific Officer Compensation: $680.65kDr. Andrew Anzalone M.D. (Age 37)Ph.D., Co-Founder & Head of Prime Editing Platform Dr. David R. Liu Ph.D.Co-Founder & Chair of Scientific Advisory BoardDr. Allan Reine M.D. (Age 49)Chief Financial Officer Dr. Meredith Goldwasser (Age 53)Senior VP and Head of Strategy & Corporate Operations Ms. Carman Alenson CPA (Age 58)M.B.A., Senior VP of Finance & Chief Accounting Officer Dr. Karen Brown J.D.Ph.D., Senior Vice President of Intellectual Property & Legal AffairsMs. Niamh AlixChief Human Resources Officer More Insider Trading Tools from MarketBeat Related Companies Arcutis Biotherapeutics Insider Trades ANI Pharmaceuticals Insider Trades Harmony Biosciences Insider Trades IDEAYA Biosciences Insider Trades Dyne Therapeutics Insider Trades Beam Therapeutics Insider Trades Recursion Pharmaceuticals Insider Trades Adaptive Biotechnologies Insider Trades Travere Therapeutics Insider Trades Immunocore Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles $100 Million Buyback in Upwork Stock Follows a Strong Quarter Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tCoreWeave and Madrigal's Insider Trades Flash Bullish SignalsPalantir Insider Selling: Risk Signal or Normal Activity?Loop Industries Insiders Buy Stock, Signal Confidence in Outlook This page (NYSE:PRME) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersFanatics Hit $31B-Is This Nasdaq Next?Fanatics built an empire by owning the fan experience-scaling to a $31B valuation. But the next wave isn't abo...i2i Marketing Group, LLC | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredFree: The Crypto Summit That Could Change Your LifeWall Street’s Crypto Playbook—Revealed at This Free Event If you want to understand what's really happening...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prime Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Prime Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRME Stock Alerts